Bill > A00344

This bill amends the New York public health law to add tianeptine sodium, a drug used to treat depression, to the list of Schedule II controlled substances. Schedule II drugs have a high potential for abuse but can be prescribed for medical use under strict regulation. The bill will take effect 90 days after it becomes law, meaning tianeptine sodium will be reclassified as a Schedule II substance in New York starting three months after the bill is enacted.